N von Ahsen Selected Research

N von Ahsen Research Topics

Disease

3	Multiple Sclerosis 01/2011 - 09/2009
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2008 - 12/2002
2	Brain Diseases (Brain Disorder) 01/2011 - 01/2004
2	Alcoholism (Alcohol Abuse) 04/2008 - 08/2000
1	Progressive Multifocal Leukoencephalopathy 01/2016
1	Protein S Deficiency (Deficiency, Protein S) 12/2011
1	Protein C Deficiency 12/2011
1	Activated Protein C Resistance (APC Resistance) 12/2011
1	Thrombophilia 12/2011
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2011
1	Central Nervous System Diseases (CNS Diseases) 01/2011
1	Encephalitis (Encephalitis, Rasmussen) 01/2011
1	Heart Failure 09/2009
1	Cardiomyopathies (Cardiomyopathy) 09/2009
1	Hyperhomocysteinemia 04/2008
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2008
1	Stroke (Strokes) 06/2004
1	Obstructive Sleep Apnea 06/2004
1	Cognitive Dysfunction 06/2004
1	Homocysteinemia 06/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2004
1	Kidney Neoplasms (Kidney Cancer) 01/2004
1	Psychotic Disorders (Schizoaffective Disorder) 01/2004
1	Schizophrenia (Dementia Praecox) 01/2004
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2004
1	alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency) 12/2002
1	Optic Nerve Diseases (Optic Neuropathy) 12/2002
1	Vascular System Injuries 12/2002
1	Hypoxia (Hypoxemia) 04/2001
1	Gilbert Disease 12/2000
1	Hyperbilirubinemia 12/2000
1	Thiopurine S methyltranferase deficiency 11/2000
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2000
1	Thrombosis (Thrombus) 09/2000
1	Seizures (Absence Seizure) 08/2000
1	Alcohol Withdrawal Seizures 08/2000

Drug/Important Bio-Agent (IBA)

7	HomocysteineIBA 12/2011 - 08/2000
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2011 - 09/2009
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2009 - 09/2009
2	Vitamin B Complex (B Vitamins)IBA 01/2008 - 01/2007
2	EnzymesIBA 12/2000 - 11/2000
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	AntithrombinsIBA 12/2011
1	Factor V (Coagulation Factor V)IBA 12/2011
1	factor V LeidenIBA 12/2011
1	Antiviral Agents (Antivirals)IBA 01/2011
1	Apolipoprotein E4IBA 04/2008
1	ApolipoproteinsIBA 04/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2004
1	Erythropoietin FDA Link 01/2004
1	Haloperidol (Haldol)FDA LinkGeneric 01/2004
1	XenobioticsIBA 01/2004
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2002
1	Peptide Hydrolases (Proteases)FDA Link 12/2002
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2001
1	Endothelin-1 (Endothelin 1)IBA 04/2001
1	Endothelin-Converting EnzymesIBA 04/2001
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 12/2000
1	CreatinineIBA 10/2000
1	Immunoglobulin M (IgM)IBA 10/2000
1	Prothrombin (Factor II)IBA 09/2000
1	homocysteic acidIBA 08/2000
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2000
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2000

Therapy/Procedure

2	Therapeutics 09/2009 - 06/2004
1	Continuous Positive Airway Pressure 06/2004